Articles
abbvie acquires cerevel to grow neuroscience drug offerings
AbbVie acquires Cerevel, expanding neuroscience portfolio with innovative treatments and therapies for neurodegenerative diseases and disorders.
Read More
abbvie autoimmune acquisition boosts immunology strength
AbbVie autoimmune acquisition boosts immunology portfolio with new treatments, expanding options for autoimmune disease patients.
Read More
abbvie allergan acquisition opens new pharma era
Discover how AbbVie Allergan acquisition transforms the pharma industry with innovative treatments, expanded portfolios, and strategic growth.
Read More
Does Abbvie Own Allergan? Industry Impact Explained
Does Abbvie own Allergan? Find out the truth and how this affects pharmaceuticals, healthcare, and the future of the industry.
Read More
AbbVie Acquisition of Cerevel Therapeutics Finalized
AbbVie completes acquisition of Cerevel Therapeutics, expanding neuroscience portfolio and advancing innovative treatments for brain disorders.
Read More
